Ordering Recommendation

Use when a diagnosis of polycythemia vera (PV) is suspected.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Whole blood or bone marrow in lavender (EDTA).

Specimen Preparation

Whole Blood: Do not freeze. Transport 5 mL whole blood. (Min: 1 mL)
Bone Marrow: Do not freeze. Transport 3 mL bone marrow. (Min: 1 mL)

Storage/Transport Temperature

Refrigerated

Unacceptable Conditions

Plasma, serum, FFPE tissue blocks/slides, or fresh or frozen tissue. Specimens collected in anticoagulants other than EDTA. Clotted or grossly hemolyzed specimens.

Remarks
Stability

Refrigerated: 7 days; Frozen: Unacceptable

Methodology

Droplet Digital PCR (ddPCR)

Performed

Varies

Reported

3-12 days

Reference Interval

Interpretive Data

Refer to report.

Compliance Category

Laboratory Developed Test (LDT)

Note

If JAK2 qualitative is reported as "Not Detected," then JAK2 Exon 12 Mutation Analysis will be added. Additional charges apply.

Hotline History

N/A

CPT Codes

81270; if reflexed, add 81279

Components

Component Test Code* Component Chart Name LOINC
3016844 JAK2 QUAL, Source 31208-2
3016845 JAK2 QUAL Mutation by PCR 43399-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • JAK2 Exon 12
  • Janus Kinase 2 Gene
  • Janus Kinase 2 Gene Sequencing
  • MPN JAK2 testing
JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to JAK2 Exon 12 Mutation Analysis by PCR